Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Arsenic Trioxide'

Posted by Staff Writer
July 29, 2001 12:00 AM

Researchers report that arsenic trioxide, a newly approved leukemia treatment, is responsible for the sudden of three leukemia patients. The patients were participating in a study of the new treatment. Acute promyelocytic leukemia (APL) is very rare. Only 800 to 1,000 people are diagnosed with APL annually in the Uni

Posted by Staff Writer
July 02, 2001 12:00 AM

Arsenic trioxide, a drug created to treat leukemia patients, has come under scrutiny by the FDA after two separate clinical trials resulted in drug-related deaths. Cell Therapeutics of Seattle, the maker of the arsenic trioxide drug Trisenox, is evaluating the results of these two trials. The medical journal Bloo

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes